PROP’s Disproportionate Influence on U.S. Opioid Policy: The Harms of Intended Consequences
Pallimed
MAY 3, 2021
The FDA acknowledged receipt of the PROP Petition on July 26, 2012 (9), and it simultaneously received a letter of support for its petition on the same date, led by Congress member, Representative Mary Bono Mack from California (10).
98 
Let's personalize your content